Melanoma Clinical Trials
Melanoma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for melanoma. Corterve aggregates actively recruiting Melanoma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Melanoma studies
- A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With MelanomaNCT06594991PHASE2Memorial Sloan Kettering Cancer CenterAdvanced MelanomaLos Angeles, California
- Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 PandemicNCT04474301M.D. Anderson Cancer CenterCOVID-19 InfectionHouston, Texas
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsNCT06418204Wake Forest University Health SciencesBreast CarcinomaFairbanks, Alaska
- IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsNCT05039801PHASE1M.D. Anderson Cancer CenterAdvanced Endometrial CarcinomaHouston, Texas
- A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)NCT06246916PHASE3Regeneron PharmaceuticalsMelanomaChandler, Arizona
- Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)NCT06545682PHASE1M.D. Anderson Cancer CenterMelanoma (Skin Cancer)Houston, Texas
- BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyNCT05136196PHASE2National Cancer Institute (NCI)Clinical Stage III Cutaneous Melanoma AJCC v8Phoenix, Arizona
- Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell CarcinomaNCT05155033PHASE2National Cancer Institute (NCI)Metastatic MelanomaBethesda, Maryland
- Phase 1 Study of PF-08046033 in Advanced Solid TumorsNCT07519655PHASE1PfizerNon-Small-Cell LungDenver, Colorado
- A Study of Therapeutic Drug Monitoring-Based Atezolizumab DosingNCT06066138PHASE1National Cancer Institute (NCI)Locally Advanced Alveolar Soft Part SarcomaBethesda, Maryland
- Evaluation for NCI Surgery Branch Clinical Research ProtocolsNCT00001823National Cancer Institute (NCI)Synovial Cell CancerBethesda, Maryland
- Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsNCT06814496PHASE1, PHASE2University of ArizonaMelanomaGilbert, Arizona
Melanoma trials by state
Melanoma trials by metro
Frequently asked questions
- How do I find recruiting Melanoma clinical trials?
- Browse the actively recruiting Melanoma studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Melanoma clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Melanoma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.